Wang Jianfeng, the Secretary of the CPC Changzhou Municipal Committee, met with Mr. Zheng Zhiheng, the Chairman of Bios Biologics
2025-05-29
On 28 May 2025, Wang Jianfeng, Party Secretary of Changzhou City, Jiangsu Province, met with Mr. Zheng Zhiheng, Chairman of Bios Biotechnology Co., LTD., Vice Chairman and Executive Director of Chow Tai Fok Jewelry Group Co., LTD., to exchange views on further deepening cooperation.
Secretary Wang Jianfeng, on behalf of Changzhou Municipal Party Committee and Municipal Government, extended a warm welcome to Mr. Zheng and his delegation's visit to Changzhou and briefly introduced the city's economic and social development. Secretary Wang Jianfeng said that currently, Changzhou is focusing on building the "1028" industrial system, vigorously fostering new high-quality productive forces. The development of related industries such as new energy, new materials, and biomedicine is rapid. Bios Biopharmaceuticals has long been dedicated to research in the field of hemoglobin oxygen carriers, accumulating rich industry experience, which is highly consistent with Changzhou's development direction. We sincerely welcome the company to continuously expand its investment and layout in Changzhou, introduce more high-end resources and quality projects, and continue to work together to achieve win-win development. Changzhou will actively create a first-class business environment and support the company to achieve better and faster development in the city.
Mr. Zheng expressed his gratitude to Changzhou for its support to Bios Biotech. It was also indicated that Changzhou has obvious geographical and industrial advantages and strong development momentum. The company will accelerate the construction and commissioning of projects in Changzhou, build a modern, intelligent and green biopharmaceutical production base, actively carry out cooperation among industry, academia and research, jointly promote technological innovation in the biopharmaceutical field, and better meet the growing health needs of the people.
BIOS Biotechnology Co., Ltd. was established in 2024, with its headquarters in Hong Kong, China. It focuses on the research and development and industrial production of biomedicines and medical devices based on hemoglobin oxygen carriers. The company's project invested and constructed in the Jintan Economic Development Zone, Changzhou City, mainly engages in the research and development and manufacturing of medical devices, drugs, and veterinary drugs, as well as multiple products centered on hemoglobin as the raw material.
-
Wang Jianfeng, the Secretary of the CPC Changzhou Municipal Committee, met with Mr. Zheng Zhiheng, the Chairman of Bios Biologics
On 28 May 2025, Wang Jianfeng, Party Secretary of Changzhou City, Jiangsu Province, met with Mr. Zheng Zhiheng, Chairman of Bios Biotechnology Co., LTD., Vice Chairman and Executive Director of Chow Tai Fok Jewelry Group Co., LTD., to exchange views on further deepening cooperation.
2025-05-29 -
Yale scientists have successfully revived a pig brain with artificial blood
Recently, the cover of Nature published the latest research from Yale University School of Medicine: scientists at Yale University used an infusion solution to successfully revive the pig brain after 4 hours of death, restoring some cellular and metabolic functions, and maintaining them for at least 6 hours.
2024-08-03 -
A brief history of research and development of red blood cell substitutes
Blood has always been a very important, but very limited medical resource.
2024-08-02 -
Application of hemoglobin oxygen carrier product HBOC-201 in the treatment of extensive burns
Treatment of burns is often accompanied by anemia and a high rate of allogeneic blood transfusion. In a study of patients with burns of 20% or more of their total surface area, Palmieri found that 75% received at least one unit of red blood cells during their hospital stay.
2024-08-01